Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study

Published:2023-12-20 Issue: Volume: Page:1-21
ISSN:1525-7770
Container-title:Nucleosides, Nucleotides & Nucleic Acids
language:en
Short-container-title:Nucleosides, Nucleotides & Nucleic Acids

Author:

Hekmatshoar Yalda¹^ORCID,Rahbar Saadat Yalda²^ORCID,Ozkan Tulin³^ORCID,Bozkurt Sureyya⁴^ORCID,Karadag Gurel Aynur⁵^ORCID

Affiliation:

1. Department of Medical Biology, School of Medicine, Altinbas University, Istanbul, Turkey

2. Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

3. Department of Medical Biology, School of Medicine, Ankara University, Ankara, Turkey

4. Department of Medical Biology, School of Medicine, Istinye University, Istanbul, Turkey

5. Department of Medical Biology, School of Medicine, Usak University, Usak, Turkey

Publisher

Informa UK Limited

Subject

Genetics,Molecular Medicine,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15257770.2023.2296021

Reference48 articles.

1. Management of chronic myeloid leukaemia: current treatment options, challenges, and future strategies

2. Characterization of imatinib-resistant K562 cell line displaying resistance mechanisms

3. Expression analysis of Akirin-2, NFκB-p65 and β-catenin proteins in imatinib resistance of chronic myeloid leukemia

4. Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia

5. First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP